• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST PAUL DELTEC TITANIUM IMPLANTABLE PORT; PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST PAUL DELTEC TITANIUM IMPLANTABLE PORT; PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV Back to Search Results
Catalog Number 21-4483-24
Device Problem Material Fragmentation (1261)
Patient Problem Foreign Body In Patient (2687)
Event Date 08/30/2023
Event Type  Injury  
Event Description
It was reported by the customer that the catheter has broken and migrated.The reservoir implantation date was (b)(6) 2019, in the subclave, in the left side.The patient reported pain around the reservoir 10 or 15 days ago and they decided to remove it due to possible infection.At that moment of the event, they detected that the catheter is not complete and that a piece is missing.The event occurred during in use with a patient; however, there was no harm or injury.The patient required interventional radiology to remove the piece of catheter.
 
Manufacturer Narrative
Other text: investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.
 
Manufacturer Narrative
Email is: regulatory.Responses@icumed.Com.One (1) unit sample was received in decontaminated condition without its original packaging.Two pictures were included where it is observed the port with a section attached to the port.No catheter has returned; however, it is observed that a section of catheter is attached in the port-catheter connection section under the sleeve, additionally brown spots are observed between the remained catheter section and the port and several punctures on the septum and septum?s housing are observed.The complaint was confirmed.A root cause for the condition was unknown and the most probable cause is that damage occurred after the product left the manufacturing facilities since the failure could not be reproduced following assembly process.A device history record (dhr) review reported no discrepancies or non-conformances during the manufacturing of the reported lot number.No corrective actions since the root cause could not be attributed to the manufacturing process.
 
Event Description
Additional information received by email, the patient received treatment with paclitaxel, adraimycin and cyclophosphamide and currently carries another port-a-cath.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTEC TITANIUM IMPLANTABLE PORT
Type of Device
PORT AND CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAV
Manufacturer (Section D)
ST PAUL
1265 grey fox rd.
st. paul MN 55112
Manufacturer (Section G)
NULL
Manufacturer Contact
jim vegel
MDR Report Key17898979
MDR Text Key325244554
Report Number3012307300-2023-09155
Device Sequence Number1
Product Code LJT
UDI-Device Identifier10610586032776
UDI-Public10610586032776
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K072657
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/01/2023
Device Catalogue Number21-4483-24
Device Lot Number3603214
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/31/2023
Initial Date FDA Received10/09/2023
Supplement Dates Manufacturer Received01/23/2024
Supplement Dates FDA Received02/22/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/30/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient SexFemale
Patient RaceWhite
-
-